Common osteoporosis drugs linked to 24% lower dementia risk in major study
Community vote
No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.
Tried-it reports
Lived experience sits next to the community vote. Official sources never override either.
A massive study of more than 120,000 older adults suggests that common osteoporosis drugs may reduce the risk of Alzheimer’s disease and other dementias by up to 24%. The surprising findings raise the possibility that medications already used to strengthen bones could also help protect the aging brain. Imported from RSS. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - ClinicalTrials.gov: Creatine and Resistance Training in Older Adults With Mild Cognitive Impairment — https://clinicaltrials.gov/study/NCT06948149
Votes and comments are community opinion, not professional advice.
Comments
No comments yet. Got receipts? Drop them.